Artiva Biotherapeutics, Inc. ($ARTV)
Filing Information
| Accession Number | 0001931382-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | May 28, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
1,432,291
Total Value
$16,499,992.32
P&L
-33.9% ($5,600,257.81)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | May 11, 2026 | Purchase | 1,085,069 | $11.52 | $12,499,994.88 | 4,391,969 | Direct | โ | View Details | |
10% Owner | Common Stock | โ | May 11, 2026 | Purchase | 347,222 | $11.52 | $3,999,997.44 | 1,607,734 | Indirect | By GC Cell Corporation | View Details |